BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17823411)

  • 41. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage.
    Bensimon A; Schmidt A; Ziv Y; Elkon R; Wang SY; Chen DJ; Aebersold R; Shiloh Y
    Sci Signal; 2010 Dec; 3(151):rs3. PubMed ID: 21139141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
    Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
    Smith J; Tho LM; Xu N; Gillespie DA
    Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Double-strand breaks in ribosomal RNA genes activate a distinct signaling and chromatin response to facilitate nucleolar restructuring and repair.
    Korsholm LM; Gál Z; Lin L; Quevedo O; Ahmad DA; Dulina E; Luo Y; Bartek J; Larsen DH
    Nucleic Acids Res; 2019 Sep; 47(15):8019-8035. PubMed ID: 31184714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.
    Falck J; Coates J; Jackson SP
    Nature; 2005 Mar; 434(7033):605-11. PubMed ID: 15758953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The ubiquitin-interacting motif containing protein RAP80 interacts with BRCA1 and functions in DNA damage repair response.
    Yan J; Kim YS; Yang XP; Li LP; Liao G; Xia F; Jetten AM
    Cancer Res; 2007 Jul; 67(14):6647-56. PubMed ID: 17621610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNAs and DNA damage response: implications for cancer therapy.
    Wang Y; Taniguchi T
    Cell Cycle; 2013 Jan; 12(1):32-42. PubMed ID: 23255103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Holliday junction recognition protein as a prognostic biomarker and therapeutic target for oral cancer.
    Tsevegjav B; Takano A; Zhu M; Yoshitake Y; Shinohara M; Daigo Y
    Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35103286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of Holliday junction-recognizing protein and its correlation with immune infiltrates in lung adenocarcinoma.
    Chen L; Zeng C; Yan L; Liao W; Zhen C; Yao J
    Oncol Lett; 2022 Jul; 24(1):232. PubMed ID: 35720487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in holliday junction recognition protein (HJURP): Structure, molecular functions, and roles in cancer.
    Li L; Yuan Q; Chu YM; Jiang HY; Zhao JH; Su Q; Huo DQ; Zhang XF
    Front Cell Dev Biol; 2023; 11():1106638. PubMed ID: 37025176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HJURP promotes proliferation in prostate cancer cells through increasing CDKN1A degradation via the GSK3β/JNK signaling pathway.
    Lai W; Zhu W; Xiao C; Li X; Wang Y; Han Y; Zheng J; Li Y; Li M; Wen X
    Cell Death Dis; 2021 Jun; 12(6):583. PubMed ID: 34099634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A pan-cancer analysis of the oncogenic role of Holliday junction recognition protein in human tumors.
    Su R; Huang H; Gao X; Zhou Y; Yin S; Xie H; Zhou L; Zheng S
    Open Med (Wars); 2022; 17(1):317-328. PubMed ID: 35274047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pan-cancer analysis based on epigenetic modification explains the value of HJURP in the tumor microenvironment.
    Li J; Zheng J; Zhang R; Zhang W; Zhang J; Zhang Y
    Sci Rep; 2022 Dec; 12(1):20871. PubMed ID: 36460821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HJURP is recruited to double-strand break sites and facilitates DNA repair by promoting chromatin reorganization.
    Serafim RB; Cardoso C; Storti CB; da Silva P; Qi H; Parasuram R; Navegante G; Peron JPS; Silva WA; Espreafico EM; Paçó-Larson ML; Price BD; Valente V
    Oncogene; 2024 Mar; 43(11):804-820. PubMed ID: 38279062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. At last, a predictive and prognostic marker for radiotherapy?
    Coates P; Dewar J; Thompson AM
    Breast Cancer Res; 2010; 12(3):106. PubMed ID: 20497617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia.
    Pergaris A; Genaris I; Stergiou IE; Klijanienko J; Papadakos SP; Theocharis S
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomic destabilization and its associated mutagenesis increase with senescence-associated phenotype expression.
    Yoshioka KI; Matsuno Y
    Cancer Sci; 2021 Feb; 112(2):515-522. PubMed ID: 33222327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA damage and chromosomal instability.
    Zierhut C
    Methods Cell Biol; 2024; 182():xvii-xx. PubMed ID: 38359991
    [No Abstract]   [Full Text] [Related]  

  • 59. Publisher Correction: Pan-cancer analysis based on epigenetic modification explains the value of HJURP in the tumor microenvironment.
    Li J; Zheng J; Zhang R; Zhang W; Zhang J; Zhang Y
    Sci Rep; 2023 Jul; 13(1):10891. PubMed ID: 37407669
    [No Abstract]   [Full Text] [Related]  

  • 60. HJURP Derived from Cancer-Associated Fibroblasts Promotes Glutamine Metabolism to Induce Resistance to Doxorubicin in Ovarian Cancer.
    Lan Y; Xu H; Jin L
    Tohoku J Exp Med; 2024 Jun; ():. PubMed ID: 38866531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.